Oncology & Cancer

Atherosclerosis: Specific microRNAs promote inflammation

(Medical Xpress)—Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet in Munich have now identified a microRNA that ...

Immunology

New insights into how immune system fights atherosclerosis

A study led by Columbia University Medical Center (CUMC) researchers has found that an important branch of the immune system, in reaction to the development of atherosclerotic lesions, mounts a surprisingly robust anti-inflammatory ...

Neuroscience

Enhanced white blood cells heal mice with MS-like disease

Genetically engineered immune cells seem to promote healing in mice infected with a neurological disease similar to multiple sclerosis (MS), cleaning up lesions and allowing the mice to regain use of their legs and tails.

Radiology & Imaging

High-strength MRI tracks multiple sclerosis progression

The development of scars, or lesions, in the brain's cortical gray matter is a powerful predictor of neurological disability for people with multiple sclerosis (MS), according to study appearing in the journal Radiology. ...

Medications

Scientists test new way to treat eczema

Researchers at Vanderbilt University Medical Center have developed a new investigational drug that can block inflammatory signaling in a preclinical model of atopic dermatitis—eczema.

Diseases, Conditions, Syndromes

Dual mode laser therapy effectively treats acne vulgaris

(HealthDay) -- A series of Nd:YAG laser treatments effectively and rapidly reduces both inflammatory and noninflammatory acne vulgaris lesions, according to a study published in the April issue of the Journal of the American ...

Diseases, Conditions, Syndromes

Clearing up common myths about psoriasis

Psoriasis is a misunderstood disease, often kept under wraps by sufferers who want to hide their skin lesions. This week, Dr. Sara Ferguson, a dermatologist at Penn State Medical Group in State College, separates fact from ...

Diseases, Conditions, Syndromes

Ivermectin tops metronidazole for papulopustular rosacea

(HealthDay)—For patients with papulopustular rosacea (PPR), once-daily ivermectin 1 percent cream (IVM 1 percent) is superior to twice-daily metronidazole (MTZ 0.75 percent) cream, according to a study published in the ...

page 2 from 4